Theme: Understanding and Reversing Polycystic Ovarian Syndrome

Pcosa 2018

Renowned Speakers

Pcosa 2018

It is with great pleasure that I welcome you to the 4th Annual World Congress on Polycystic Ovarian Syndrome. Last year, 2017, the event was hosted by the medical professions and pioneers of PCOS awareness; the PCOS Awareness Association. This year’s event will serve as a continuation of the excellent progress we made in our past conference.

The theme of this year’s conference is “Understanding and Reversing Polycystic Ovarian Syndrome An estimated 10% of women suffer from PCOS with most of them unaware of the symptoms. It is imperative that efforts of education, support, treatment and care begin with us. Our shared interest of this conference is to generate resources and share knowledge in our quest to bring awareness, educate and ultimately, care and support to the community affected by PCOS.

This year’s congress will feature engaging sessions by leading experts and speakers on Polycystic Ovarian Syndrome, Effects of PCOS on Women’s Health, Endometriosis, Ovarian Cyst, PCOS- Medications and Treatment, Alternative PCOS Treatment, PCOS and Pregnancy, PCOS in Teens and Adolescents: Early Diagnosis and Intervention, Medical Diagnosis of PCOS, Prevention and Management of PCOS, Advanced Management of PCOS, Recent Research and Current Advancements in PCOS Treatment and Advanced Polycystic Ovarian Diseases Treatment.

Our aim is to bring together professionals and experts of various specializations in our continuous effort to create awareness and provide treatment and care to women affected by PCOS. We are confident that this year’s world congress will yield active participation of Obstetrics Gynaecologists, Reproductive Endocrinologists, Pathologists, Research Scholars, Industrial Professionals and Student delegates from biomedical and healthcare sectors. 

It is my privilege to welcome you to this year’s event. I encourage us to come together with the same zest and alacrity as last year to make this year’s world congress a monumental success. Change and progress begin with us.

Sincerely Yours, 
Megan M Stewart
Founder and Executive Director
PCOS Awareness Association

Details of PCOS Conference 2018 in USA

Conference Series LLC Ltd  officially welcomes you to attend the 4th  World Congress on Polycystic Ovarian Syndrome during October 26-27, 2018 at Boston, Massachusetts, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Special interest and theme of this conference is to Understanding and Reversing Polycystic Ovarian Syndrome

Polycystic ovarian syndrome (PCOS), is a set of symptoms due to a hormone imbalance in women. Women with PCOS may have enlarged ovaries that contain small collections of fluid called follicles located in each ovary. Multiple cysts are formed due to hormonal imbalance.

Conference Series LLC Ltd Organizes 300+ Scientific Conferences every year across USA, Europe & Asia. Besides 500 Peer reviewed, Open Access Journals, Conference Series LLC Ltd  has collaborated with more than 1000 Scientific Associations and institutions worldwide to promote information on medicine, health care and technologies. These journals are enjoying the support of over 5 million readers; a team of 30.000 eminent scholars are providing editorial support. Conference Series LLC Ltd   Medical Conferences provides an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.

Conference Series LLC Ltd  Conferences invites all the participants from all over the world to attend “4th World Congress on Polycystic Ovarian Syndrome during October 26-27, 2018 in Boston, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

PCOS Conference 2018 is a global platform to discuss and learn about PCOS and its Associated Diseases Polycystic Ovarian Syndrome, Effects of PCOS on Womens Health, Endometriosis, Ovarian Cyst, PCOS- Medications and Treatment, Alternative PCOS Treatment, PCOS and Pregnancy, PCOS in Teens and Adolescents: Early Diagnosis and Intervention, Medical Diagnosis of PCOS, Prevention and Management of PCOS, Advanced Management of PCOS, Recent Research and Current Advancements in PCOS Treatment, Advanced Polycystic Ovarian Diseases Treatment

Track 1: Polycystic Ovarian Syndrome

Insulin is a hormone produced in the pancreas that allows cells to use sugar. Excess insulin may also affect the ovaries by increasing androgen production, which may interfere with the ovaries' ability to ovulate.

White blood cells (WBC) produce substances to fight infection as a part of a response meachanism called inflammation. Research has shown that women with PCOS have low-grade inflammation and this type of low-grade inflammation stimulates polycystic ovaries to produce androgens.

Hormones are the chemical messengers in the body that travel through the bloodstream to the organs and tissues. They work slowly via feedback mechanisms with other glands and organs, affecting many of the body's processes over time. Endocrine glands, which are special groups of cells, genertae hormones. The infertility rates  due to polycystic ovaries are very high. Women usually will have difficulty getting pregnant - and usually require treatment to improve chances of pregnancy. Diabetes mellitus, commonly referred to as diabetes, is a group of metabolic diseases which accompanies high blood sugar levels over a prolonged period.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

Related Association & Society:PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations),  American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia ,  Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association : Endocrine Society

Track 2: Effects of PCOS on Women's Health

Endometrial cancer is a cancer which arises from the endometrium. It is a result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with menstrual periods. Other symptoms include pain with urination or sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause. Hyperandrogenism is one of the primary symptoms of polycystic ovary syndrome (PCOS). In such cases, it presents with symptoms such as acne and seborrhea, is frequent in adolescent girls and is often associated with irregular menstrual cycles.

Dyslipidaemia, diabetes, and obesity are all potent cardiovascular risk factors that tend to cluster in women with PCOS. However, it is not known whether the increased cardiovascular risks seen in PCOS are mediated through obesity and is independent of body mass index (BMI) and the result of other metabolic factors.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

 American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia , Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association : Endocrine Society PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Track 3: Endometriosis

Endometriosis is a disease in which tissue that normally grows inside the uterus grows outside the uterus. Its main symptoms are pelvic pain and infertility. Nearly half of the patients suffering from this encounters chronic pelvic pain, while in 70% of them pain occurs during menstruation. Pain during sex is also common. Infertility occurs in up to half of the people. Less common symptoms include urinary or bowel symptoms. About 25% of women have no symptoms. Endometriosis can have both social and psychological effects. Hormonal contraceptives birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrial tissue each month. Gonadotropin-releasing hormone (Gn-RH) agonists and antagonists are drugs that block the production of ovarian-stimulating hormones, lowering oestrogen levels and preventing menstruation. Medroxyprogesterone (Depo-Provera) is an injectable drug which is effective in halting menstruation and the growth of endometrial implants, thereby relieving the signs and symptoms of endometriosis.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

 Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia : Endocrine Society PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Track 4: Ovarian Cyst

An ovarian cyst is any collection of fluid, surrounded by a very thin wall, within an ovary. Any ovarian follicle that is larger than about two centimetres is termed an ovarian cyst. Such cysts range in size from as small as a pea to larger than an orange. Ovarian cysts occur in women of all ages including neonatal period and even infancy. They are most prevalent during infancy, adolescence and during the childbearing years. With ultrasonography ovarian cysts can be demonstrated in nearly all premenopausal and approximately 18% postmenopausal women

Polycystic ovarian cancer is a heterogeneous disorder of uncertain cause. There is strong evidence that it is a genetic disease. Such evidences include the familial clustering of cases, greater concordance in monozygotic compared with dizygotic twins and heritability of endocrine and metabolic features of PCOS.

Ovarian cancer warning signs include ongoing pain or cramps in the lower abdomen or back, abnormal vaginal bleeding, nausea, and bloating. Depending on the cancer stage, ovarian cancer treatment includes surgery and chemotherapy

There are two types of Ovarian Cyst Surgery

Laparoscopy

Most cysts can be removed using laparoscopy. This is a type of keyhole surgery where small cuts are made on the abdominal surface and gas is blown into the pelvis to allow the surgeon to access your ovaries.

Laparotomy

During a laparotomy, a single, larger cut is made on the abdominal surface to give the surgeon a better access to the cyst. The whole cyst and ovary may be removed and sent to a laboratory to check whether it's cancerous or not. Stitches or staples are used to close the incision.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

 American Association Of Clinical Endocrinologists ; Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia : Endocrine Society PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Track 5: PCOS- Medications and Treatment

Clomiphene therapy is typically used for five consecutive days early in the menstrual cycle, for three to six monthly cycles. It may take several cycles to find the right dose to stimulate ovulation. After that dose is determined, a woman will take the drug for at least three more cycles.

Drugs used in the treatment of polycystic ovarian syndrome (PCOS) include metformin (off-label use), spironolactone, eflornithine, and oral contraceptives. Oral contraceptives containing a combination of oestrogen and progestin increase sex hormone–binding globulin (SHBG) levels and thereby reduce the free testosterone level. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels are also suppressed. This restores cyclic exposure of the endometrium to estrogen-progestin, with the resumption of menstrual periods and decreased hirsutism. However, the use of oral contraceptives may be associated with an increased risk of thrombosis and metabolic abnormalities.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations),  American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia ,  Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association : Endocrine Society

Track 6: Alternative PCOS Treatment

Polycystic ovarian disease (PCOD) is a common hormonal disorder among women of reproductive age. It is a condition where hormonal imbalance affects the follicular growth during the ovarian cycle, causing the affected follicles to remain in the ovary.

Ayurveda classifies PCOS as a kapha disorder. Kapha having first affected the digestive fire – jatharaagni starts to affect the metabolic aspect of the seven tissues called dhatu agni. Each dhatu agni is responsible for the nourishment and formation of that particular tissue that it resides in.

Ayurvedic for Polycystic ovarian syndrome diet focuses on developing healthy Aartava (Female reproductive tissue-one of the dhatu).  A diet for patients with PCOS includes fresh fruits and vegetables. Also are recommend fresh fruits such as peaches, pears, plums as well as dried fruits such as dates, figs and raisins

Poly cystic ovarian syndrome can result in infertility issues. It can also be treated naturally through diet and herbal remedies.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia : Endocrine Society PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Track 7: PCOS and Pregnancy

“Infertility" is a term used to describe the inability of a woman or man to conceive a child or the inability of a woman to carry a pregnancy to term.

Ovulation is the result of a maturation process which occurs in the hypothalamic-pituitary-ovarian (HPO) axis and is orchestrated by a neuroendocrine cascade terminating in the ovaries. Any alteration results in a failure to release a mature ovum, leading to anovulatory cycles. Anovulation may manifest in a variety of clinical presentations, from luteal insufficiency to oligomenorrhea.

Anovulation is a not a disease but a sign, much in the same way as that of the which polycystic ovaries manifestation which is part of a much larger disease process.

Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to another organ system, often the kidneys. Preeclampsia usually begins after 20 weeks of pregnancy in a woman whose blood pressure had been normal. Even a slight rise in blood pressure may be a sign of preeclampsia.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

American Association Of Clinical Endocrinologists ; Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia : Endocrine Society PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Track 8: PCOS in Teens and Adolescents: Early Diagnosis and Intervention

Diagnosing PCOS in adolescents require a unique set of criteria for which no single marker currently exists. Adolescents at high risk of developing the syndrome are prone to congenital virilization, low birth weight, premature pubarche, central precocious puberty, large for gestational age girls born to overweight mothers, obesity syndromes, insulin-resistant features, and girls born to mothers with PCOS, central obesity, or diabetes in whom PCOS ought to be suspected when associated with irregular menses.

Neurologic and psychiatric disorders occur commonly in adolescents. Conditions such as epilepsy, migraines, and bipolar disorders which typical disorders that require chronic medication to treat symptoms and prevent recurrence of episodes.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

Endocrine Society ; American Association Of Clinical Endocrinologists ; Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia ; PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Track 9: Medical Diagnosis of PCOS

Pelvic laparoscopy is called a minimally invasive procedure because only small incisions are made. Smaller incisions often allow patients to experience a shorter recovery period, less blood loss, and lower levels of post-surgical pain than in open surgery.

Ultrasound tests use high-frequency sound waves to allow doctors to see your internal organs. The sound waves bounce off the organs, creating images of their structures. A transvaginal ultrasound is a kind of pelvic ultrasound that is used to see reproductive organs like the uterus, ovaries, cervix, and vagina.

The endometrial biopsy is a medical procedure which involves taking a tissue sample from the lining of the uterus. The tissue subsequently undergoes a histologic evaluation which aids the physician in formulating a diagnosis.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

PCOS foundation ; Endocrine Society ; American Association Of Clinical Endocrinologists ; Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia ; PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Track 10: Prevention and Management of PCOS

Polycystic ovary syndrome cannot be prevented. But early diagnosis and treatment helps prevent long-term complications, such as infertility, metabolic syndrome, obesity, diabetes, and heart disease. Polycystic ovarian syndrome is the most common manifestation of hormonal dysfunction in reproductive-age women today. PCOS is a heterogeneous condition, both clinically and biochemically. The prevalence of PCOS is reported to be anywhere between 4% and 12%, with mild racial variations.  

The menstrual irregularity of PCOS typically manifests in the peripubertal period, although some women may apparently have regular cycles at first and subsequently develop menstrual irregularity in association with weight gain. Menstrual irregularities include mild or severe oligomenorrhea or amenorrhea. Anovulation is very common in the presence of mild oligomenorrhea, and also when normal cycles are present.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

American Association Of Clinical Endocrinologists ; Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia ; PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Track 11: Advanced Management of PCOS

Weight loss, in the context of medicine, health, or physical fitness, refers to a reduction of the total body mass, due to a mean loss of fluid, body fat or adipose tissue and/or lean mass, namely bone mineral deposits, muscle, tendon, and other connective tissue. Weight loss can either occur unintentionally due to malnourishment or an underlying disease or arise from a conscious effort to improve an actual or perceived overweight or obese state.

Polycystic Ovarian Syndrome, often shortened to PCOS is a condition which affects approximately 10-15% of women within reproductive age. PCOS affect the ovaries, the organs in a woman’s body which produce eggs, and typically means that there are a number of minute cysts around the edge of the ovaries, hence the term polycystic. It is also characterised by excess production of androgens (male-type hormones such as testosterone).

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations) ; Endocrine Society ; American Association Of Clinical Endocrinologists ; Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia;

Track 12: Recent Research and Current Advancements in PCOS Treatment

Potential areas of further research activity include the analysis of predisposing conditions that increase the risk of PCOS, particularly genetic background and environmental factors, such as endocrine disruptors and lifestyle. The concept that androgen excess may contribute to insulin resistance needs to be re-examined from a developmental perspective, since animal studies have supported the hypothesis that early exposure to modest androgen excess is associated with insulin resistance.

Defining alterations of steroidogenesis in PCOS should quantify ovarian, adrenal and extraglandular contributions, as well as clearly defined blood reference levels by some universal standard. Intraovarian regulation of follicle development and mechanisms of follicle arrest should be further elucidated.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

American Association Of Clinical Endocrinologists ; Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia;  PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations) ; Endocrine Society ;

Track 13: Advanced Polycystic Ovarian Diseases treatment

The PCOS diagnoses are generally made through clinical signs and symptoms. The doctor will want to exclude other illnesses that have similar features, such as low thyroid hormone levels in blood or elevated levels of a milk-producing hormone .Also, tumors of the ovary or adrenal glands can produce elevated male hormone levels in blood that cause acne or excess hair growth, mimicking symptoms of PCOS.

The cysts (fluid filled sacs) in the ovaries can be identified by imaging technology. Ultrasound imaging employs no injected dyes or radiation and is safe for all patients including pregnant women. It can also detect cysts in the kidneys of a foetus.

Recommended PCOS Conferences | PCOS Meetings | PCOS Events | Conference Series LLC Ltd 

Endocrine Society ; American Association Of Clinical Endocrinologists ; Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association ; American Society Reproductive Medicine, Polycystic Ovary Syndrome Association of Australia ; PCOSAA (  Polycystic Ovarian Syndrome Awareness Associations)

Summary

PCOS-2018 welcomes attendees, presenters, and exhibitors from all over the world to San Antonio, USA. We are delighted to invite you all to attend and register for the “4th World Congress on Polycystic Ovarian Syndrome” which is going to be held during October 26-27, 2018 in Boston, Massachusetts, USA.

This conference mainly focuses on spreading the awareness about challenges in this field to prevent the Polycystic Ovary Syndrome diseases.

The conference throws light on thought provoking topics and recent research in the field of Polycystic Ovary Syndrome like, affect a woman’s hormone levels, periods, and ovulation.  Also called hyper androgenic anovulation or Stein –Leventhal Syndrome.  That includes various research areas such as   Obstetrics Gynecology, Reproductive   Endocrinology and Infertility, pathology, internal medicine, clinical laboratory, physiology, immunology and pediatrics. This conference will witness a conglomeration of various arenas in Polycystic ovarian Syndrome and as it involves a vast range of medical streams within it, this conference will be an excellent platform for interdisciplinary interactions, to exchange and share knowledge under a single roof.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the   PCOS 2018,   where you will be sure to have a meaningful experience with scholars from around the world. All members of the PCOS-2018 organizing committee look forward to meeting you in Boston, USA.

For more details please visit- http://pcosa.conferenceseries.com/

Importance & Scope:

PCOS 2018 is expected to offer the best platform for the expertise, researchers, students and business  delegates  with its well organized scientific program covering every minute detail about  Polycystic ovary syndrome (PCOS) is a true syndrome, from the basic causes behind PCOS disease to the latest trends in diagnostic and treatment of PCOS disease. This international event is an effort to find a weapon against Endocrine disorders   being a heterogeneous collection of signs and symptoms that gathered together form a spectrum of a disorder with a mild presentation in some, whilst in others there is a severe disturbance of reproductive, endocrine and metabolic function. There has been much debate about phenotype and, more recently, genotype. There has also been   scepticism in some quarters, with a feeling that we may be looking at one end of a spectrum that is in reality `normal', or perhaps a consequence of the modern disease of obesity. Whilst the polycystic ovary is at the centre of the syndrome, it is external effects such as   hyperinsulinism that influence its expression.  There is no consensus on the definition of   PCOS   and so studies that compare epidemiology and treatments often have very different starting points, and so cannot be compared.  Which give a better insight about the associated causes and   disease portfolio.

Conference Series LLC Ltd welcomes all   the Obstetrics Gynecologists, Reproductive Endocrinologist, pathologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed PCOS 2018.

Why Boston (USA)?

Boston is the capital city and most crowded region of the Commonwealth of Massachusetts in the United States. The city legitimate spreads 48 square miles (124 km2) with an expected populace of 673,184 of every 2016, making it the biggest city in New England and the 22nd most crowded city in the United States. The city is the financial and social stay of a considerably bigger metropolitan range known as Greater Boston, a metropolitan measurable territory (MSA) home to a statistics evaluated 4.8 million individuals in 2016 and positioning as the tenth-biggest such zone in the nation. It was the scene of a few key occasions of the American Revolution, for example, the Boston Massacre, the Boston Tea Party, the Battle of Bunker Hill, and the Siege of Boston. Its rich history pulls in numerous voyagers, with Faneuil Hall alone illustration more than 20 million guests for every year and furthermore makes an extensive part out of Boston's economy, with 21.2 million residential and global guests burning through $8.3 billion of every 2011; barring guests from Canada and Mexico, more than 1.4 million worldwide travelers went to Boston in 2014, with those from China and the United Kingdom driving the rundown. Boston's status as a state capital and additionally the local home of elected offices has rendered law and government to be another significant segment of the city's economy. The city is a noteworthy seaport along the East Coast of the United States and the most established ceaselessly worked mechanical and angling port in the Western Hemisphere.

Why to attend???

In today's economic climate your business decisions are as crucial as ever. Polycystic Ovarian Syndrome Conference allows you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. 4th World Congress on Polycystic Ovarian Syndrome Conference is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading specialists involved in Polycystic Ovarian Syndrome   and Endocrine disorders. Your organization will benefit with excellent exposure to the leaders in Obstetrics Gynecologists and Metabolic disorders.PCOS-2018 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.

Major Polycystic Ovarian Syndrome Related Associations around the Globe :

Androgen Excess and Polycystic Ovary Syndrome(AE-PCOS)Society

Endocrine Society (USA)

American Dietetic Association

American Society Reproductive Medicine

American Association Of Clinical Endocrinologists

The European Society of Human Reproduction and Embryology

Australian Breastfeeding  Association

Polycystic Ovary Syndrome Association of Australia

The Association of UK Dietitians

Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association

Association for Fertility and Reproductive Health, Nigeria

Target Audience:

Obstetrics and Gynecologists, Reproductive Endocrinologist & Infertility, Womens Health CareReproductive System & Sexual Disorders, Academicians, Clinicians, Researchers, Physical therapists, Health care professionals, students, business delegates and Young researchers.

Companies associated with PCOS in Global:

  •      Sanofi
  •      Novartis AG
  •      Teva Pharmaceutical Industries Limited 
  •      Addex Therapeutics Ltd. 
  •       BIOCAD
  •       Merck KGaA
  •       AstraZeneca plc.
  •      Bristol Myers Squibb Co. 
  •       Ferring Pharmaceuticals, Inc.
  •       Crinetics Pharmaceuticals, Inc

Market Value in US million dollars for Polycystic Ovarian Syndrome Research

The global PCOS drugs market has been segmented into five major regions namely North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. In terms of value, North America and Europe are estimated to dominate the market, collectively accounting for 57% share of the overall market by the end of 2017. Latin America and Asia Pacific are estimated to be the fastest growing emerging markets. Revenue from the APAC market is expected to expand at a robust CAGR of 5.5% during the forecast period.

Global Data estimates that the global PCOS therapeutics market was valued at $656m in 2010, and is expected to grow at a static Compound Annual Growth Rate (CAGR) of 2.6% over the next eight years, to reach $804m by 2018. The growing treated population which is mainly due to expanding prevalence of co-morbid conditions such as diabetes, obesity and dyslipidemia will drive steady growth in PCOS therapeutics market.

Market Growth of Polycystic Ovarian Syndrome Research

The Polycystic Ovarian Syndrome Market Will Start Growing From 2013 Due To the Increase in Disease Prevalence and Prescription Rates and Will Rise to $702m In 2019. The global market for PCOS drugs is on an upward swing given the increasing number of cases of patients inflicted with the disease. The global polycystic ovary syndrome drugs market revenue is estimated to reach US$ 1,154.8 Mn by 2024, expanding at a CAGR of 4.6% during the forecast period (2016–2024).

 

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://pcosa.conferenceseries.com/sponsors.php

References:

  1. http://www.prnewswire.com/news-releases/polycystic-ovarian-syndrome-pcos-therapeutics---pipeline-assessment-and-market-forecasts-to-2018-132680453.html
  2. http://en.wikipedia.org/wiki/Metformin
  3. https://www.google.co.in/?gfe_rd=cr&ei=D4HUVIOrB6XV8geijYGQAw&gws_rd=ssl#q=TOP+universities+polycystic+ovarian+syndrome+in+USA
  4. https://www.google.co.in/?gfe_rd=cr&ei=D4HUVIOrB6XV8geijYGQAw&gws_rd=ssl#q=TOP+universities++of+polycystic+ovarian+syndrome+in+world+wide&start=10
  5. http://www.lef.org/Protocols/Female-Reproductive/Polycystic-Ovary-Syndrome/Page-01
  6. http://pcoshealthcoach.com/pcos-diet-grocery-shopping-on-a-budget-my-top-tips
  7. http://www.aafp.org/afp/2003/0815/p697.html

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 26-27, 2018
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View

Media Partners